Evidence map›Paper›PMID 41838943›Full record

ArticleEmerging microbes & infections2026

Accelerated mutator phenotype in a clinical

Yinggai Song, Margriet W J Hokken, Jan Zoll, Hanka Venselaar, Paul E Verweij, Willem J G Melchers, Johanna Rhodes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Genotype-Phenotype Relationships in Azole-ResistantJournal of fungi (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yinggai SongDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, People's Republic of China.
Margriet W J HokkenDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Jan ZollDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Hanka VenselaarDepartment of Medical BioSciences, Radboudumc, Nijmegen, the Netherlands.
Paul E VerweijDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Willem J G MelchersDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Johanna RhodesDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The opportunistic pathogen

Indexed as

AspergillosisAspergillus fumigatusAntifungal AgentsAzolesDrug Resistance, FungalFungal ProteinsHumansMicrobial Sensitivity TestsMutationMutation RatePhenotypePolymorphism, Single NucleotideAntifungal AgentsAzolesFungal Proteinsantifungal resistanceAspergillus fumigatusazole therapyMre11mutator phenotype

Identifiers

PMID41838943
PMCPMC12997362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.